Haloperidol Richter (Haloperidol)

Haloperidol Richter is prescribed for several psychiatric disorders where dopamine blockade can reduce symptoms. It is commonly used in clinical practice for managing psychotic and related conditions.

• Schizophrenia, including acute exacerbations and maintenance therapy.
• Acute psychotic episodes associated with mood disorders or substance use.
• Manic episodes in bipolar disorder when rapid symptom control is needed.
• Tourette syndrome to lessen motor and vocal tics.
• Severe agitation or aggression in hospitalized patients.

Side effects of haloperidol may vary in frequency and severity. Patients should be aware of both common reactions and less frequent but serious adverse events that require medical attention.

Common

• Drowsiness or sedation.
• Extrapyramidal symptoms such as tremor or rigidity.
• Dry mouth and increased thirst.
• Constipation or gastrointestinal discomfort.

Serious

• Neuroleptic malignant syndrome, a life‑threatening reaction.
• Tardive dyskinesia with persistent involuntary movements.
• Severe hypotension or cardiac arrhythmias.
• Elevated prolactin levels causing hormonal disturbances.

Before starting Haloperidol Richter, clinicians evaluate patient history and monitor for conditions that could increase risk. Specific warnings guide safe use and ongoing assessment.

• History of cardiovascular disease or arrhythmias.
• Known sensitivity to butyrophenone antipsychotics.
• Current or past diagnosis of Parkinson’s disease or other movement disorders.
• Pregnancy or breastfeeding status, due to limited safety data.
• Concurrent use of other central nervous system depressants.
• Elderly patients, especially with dementia-related psychosis, due to higher fall risk.

Haloperidol can interact with several medications, altering its effectiveness or increasing toxicity. Identifying drugs to avoid or use cautiously helps minimize adverse outcomes.

Avoid

• Other dopamine antagonists that may intensify extrapyramidal effects.
• Medications that prolong the QT interval, such as certain antiarrhythmics.
• Strong CYP3A4 inhibitors that can raise haloperidol plasma levels.

Use with caution

• CNS depressants like benzodiazepines, which may increase sedation.
• Anticholinergic agents that can mask extrapyramidal symptoms.
• Lithium or other mood stabilizers, requiring close monitoring of neurological status.